HEADER TRANSCRIPTION 30-AUG-14 4UYE TITLE BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-DIMETHYL-2-OXO-6-( TITLE 2 PIPERIDIN-1-YL)-2,3-DIHYDRO-1H-1,3-BENZODIAZOL-5-YL-2- TITLE 3 METHOXYBENZAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEREGRIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BROMODOMAIN, UNP RESIDUES 622-738; COMPND 5 SYNONYM: BROMODOMAIN AND PHD FINGER-CONTAINING PROTEIN 1, PROTEIN COMPND 6 BR140; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSCRIPTION, INHIBITOR, HISTONE, EPIGENETIC READER, ANTAGONIST EXPDTA X-RAY DIFFRACTION AUTHOR C.CHUNG,P.BAMBOROUGH,E.DEMONT REVDAT 2 03-DEC-14 4UYE 1 JRNL REVDAT 1 17-SEP-14 4UYE 0 JRNL AUTH E.H.DEMONT,P.BAMBOROUGH,C.W.CHUNG,P.D.CRAGGS,D.FALLON, JRNL AUTH 2 L.J.GORDON,P.GRANDI,C.I.HOBBS,J.HUSSAIN,E.J.JONES,A.LE GALL, JRNL AUTH 3 A.M.MICHON,D.J.MITCHELL,R.K.PRINJHA,A.D.ROBERTS, JRNL AUTH 4 R.J.SHEPPARD,R.J.WATSON JRNL TITL 1,3-DIMETHYL BENZIMIDAZOLONES ARE POTENT, SELECTIVE JRNL TITL 2 INHIBITORS OF THE BRPF1 BROMODOMAIN. JRNL REF ACS MED.CHEM.LETT. V. 5 1190 2014 JRNL REFN ISSN 1948-5875 JRNL PMID 25408830 JRNL DOI 10.1021/ML5002932 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 95.35 REMARK 3 NUMBER OF REFLECTIONS : 30953 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.17693 REMARK 3 R VALUE (WORKING SET) : 0.17569 REMARK 3 FREE R VALUE : 0.20113 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1639 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.650 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.693 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2181 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.46 REMARK 3 BIN R VALUE (WORKING SET) : 0.227 REMARK 3 BIN FREE R VALUE SET COUNT : 120 REMARK 3 BIN FREE R VALUE : 0.262 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1855 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 240 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.793 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00 REMARK 3 B22 (A**2) : 0.00 REMARK 3 B33 (A**2) : 0.00 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.093 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.091 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.057 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.037 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.957 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1962 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1370 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2656 ; 1.183 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3319 ; 0.820 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 225 ; 4.813 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 106 ;32.370 ;24.340 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 347 ;11.323 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;10.519 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 276 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2171 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 417 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 629 A 737 REMARK 3 ORIGIN FOR THE GROUP (A): 1.4942 58.4618 16.6999 REMARK 3 T TENSOR REMARK 3 T11: 0.1054 T22: 0.0423 REMARK 3 T33: 0.2696 T12: -0.0256 REMARK 3 T13: -0.0036 T23: 0.0058 REMARK 3 L TENSOR REMARK 3 L11: 0.5890 L22: 1.5553 REMARK 3 L33: 0.2855 L12: 0.0678 REMARK 3 L13: 0.3795 L23: 0.2213 REMARK 3 S TENSOR REMARK 3 S11: -0.0459 S12: -0.0101 S13: -0.0831 REMARK 3 S21: -0.0822 S22: 0.0941 S23: 0.0736 REMARK 3 S31: -0.0641 S32: 0.0310 S33: -0.0481 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 629 B 737 REMARK 3 ORIGIN FOR THE GROUP (A): -19.0364 59.7956 6.7571 REMARK 3 T TENSOR REMARK 3 T11: 0.1314 T22: 0.0360 REMARK 3 T33: 0.2442 T12: 0.0025 REMARK 3 T13: -0.0045 T23: -0.0041 REMARK 3 L TENSOR REMARK 3 L11: 0.1407 L22: 1.6308 REMARK 3 L33: 0.3173 L12: 0.1398 REMARK 3 L13: 0.1622 L23: -0.1228 REMARK 3 S TENSOR REMARK 3 S11: -0.0415 S12: -0.0108 S13: -0.0445 REMARK 3 S21: 0.0294 S22: 0.0444 S23: -0.0957 REMARK 3 S31: -0.0533 S32: -0.0717 S33: -0.0029 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 4UYE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-SEP-14. REMARK 100 THE PDBE ID CODE IS EBI-61642. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAY-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS 6M) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32628 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.65 REMARK 200 RESOLUTION RANGE LOW (A) : 49.47 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 75.7 REMARK 200 DATA REDUNDANCY : 3.3 REMARK 200 R MERGE (I) : 0.06 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.40 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.2 REMARK 200 R MERGE FOR SHELL (I) : 0.35 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.00 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES/IMIDAZOLE PH 6.5, 10% REMARK 280 MORPHEUS DIVALENTS MPD_P1K_P3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.53000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.06000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.53000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.06000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 621 REMARK 465 GLN A 622 REMARK 465 GLN A 623 REMARK 465 ILE A 624 REMARK 465 ALA A 625 REMARK 465 MET A 626 REMARK 465 GLU A 627 REMARK 465 MET A 628 REMARK 465 LYS A 738 REMARK 465 GLY B 621 REMARK 465 GLN B 622 REMARK 465 GLN B 623 REMARK 465 ILE B 624 REMARK 465 ALA B 625 REMARK 465 MET B 626 REMARK 465 GLU B 627 REMARK 465 MET B 628 REMARK 465 LYS B 738 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2020 O HOH A 2101 4556 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2008 DISTANCE = 7.11 ANGSTROMS REMARK 525 HOH B2089 DISTANCE = 6.35 ANGSTROMS REMARK 525 HOH B2109 DISTANCE = 5.18 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A1738 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9F9 A1739 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9F9 B1738 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UYD RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3- REMARK 900 DIMETHYL-2-OXO-2,3-DIHYDRO-1H-1,3-BENZODIAZOLE-5- REMARK 900 CARBOXAMIDE REMARK 900 RELATED ID: 4UYF RELATED DB: PDB REMARK 900 THE DISCOVERY OF I-BET726 (GSK1324726A), A POTENT REMARK 900 TETRAHYDROQUINOLINE APOA1 UP-REGULATOR AND SELECTIVE BET REMARK 900 BROMODOMAIN INHIBITOR REMARK 900 RELATED ID: 4UYG RELATED DB: PDB REMARK 900 THE DISCOVERY OF I-BET726 (GSK1324726A), A POTENT REMARK 900 TETRAHYDROQUINOLINE APOA1 UP-REGULATOR AND SELECTIVE BET REMARK 900 BROMODOMAIN INHIBITOR REMARK 900 RELATED ID: 4UYH RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-((2R,4S REMARK 900 )-2-METHYL-4-(PHENYLAMINO)-6-(4-(PIPERIDIN-1-YLMETHYL REMARK 900 )PHENYL)-3,4-DIHYDROQUINOLIN-1(2H)-YL)ETHANONE DBREF 4UYE A 622 738 UNP P55201 BRPF1_HUMAN 622 738 DBREF 4UYE B 622 738 UNP P55201 BRPF1_HUMAN 622 738 SEQADV 4UYE GLY A 621 UNP P55201 EXPRESSION TAG SEQADV 4UYE GLY B 621 UNP P55201 EXPRESSION TAG SEQRES 1 A 118 GLY GLN GLN ILE ALA MET GLU MET GLN LEU THR PRO PHE SEQRES 2 A 118 LEU ILE LEU LEU ARG LYS THR LEU GLU GLN LEU GLN GLU SEQRES 3 A 118 LYS ASP THR GLY ASN ILE PHE SER GLU PRO VAL PRO LEU SEQRES 4 A 118 SER GLU VAL PRO ASP TYR LEU ASP HIS ILE LYS LYS PRO SEQRES 5 A 118 MET ASP PHE PHE THR MET LYS GLN ASN LEU GLU ALA TYR SEQRES 6 A 118 ARG TYR LEU ASN PHE ASP ASP PHE GLU GLU ASP PHE ASN SEQRES 7 A 118 LEU ILE VAL SER ASN CYS LEU LYS TYR ASN ALA LYS ASP SEQRES 8 A 118 THR ILE PHE TYR ARG ALA ALA VAL ARG LEU ARG GLU GLN SEQRES 9 A 118 GLY GLY ALA VAL LEU ARG GLN ALA ARG ARG GLN ALA GLU SEQRES 10 A 118 LYS SEQRES 1 B 118 GLY GLN GLN ILE ALA MET GLU MET GLN LEU THR PRO PHE SEQRES 2 B 118 LEU ILE LEU LEU ARG LYS THR LEU GLU GLN LEU GLN GLU SEQRES 3 B 118 LYS ASP THR GLY ASN ILE PHE SER GLU PRO VAL PRO LEU SEQRES 4 B 118 SER GLU VAL PRO ASP TYR LEU ASP HIS ILE LYS LYS PRO SEQRES 5 B 118 MET ASP PHE PHE THR MET LYS GLN ASN LEU GLU ALA TYR SEQRES 6 B 118 ARG TYR LEU ASN PHE ASP ASP PHE GLU GLU ASP PHE ASN SEQRES 7 B 118 LEU ILE VAL SER ASN CYS LEU LYS TYR ASN ALA LYS ASP SEQRES 8 B 118 THR ILE PHE TYR ARG ALA ALA VAL ARG LEU ARG GLU GLN SEQRES 9 B 118 GLY GLY ALA VAL LEU ARG GLN ALA ARG ARG GLN ALA GLU SEQRES 10 B 118 LYS HET EDO A1738 4 HET 9F9 A1739 29 HET 9F9 B1738 29 HETNAM EDO 1,2-ETHANEDIOL HETNAM 9F9 N-[1,3-DIMETHYL-2-OXO-6-(PIPERIDIN-1-YL)-2,3- HETNAM 2 9F9 DIHYDRO-1H-BENZIMIDAZOL-5-YL]-2- HETNAM 3 9F9 METHOXYBENZAMIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO C2 H6 O2 FORMUL 3 9F9 2(C22 H26 N4 O3) FORMUL 4 HOH *240(H2 O) HELIX 1 1 GLN A 629 LYS A 647 1 19 HELIX 2 2 ASP A 664 ILE A 669 1 6 HELIX 3 3 ASP A 674 ALA A 684 1 11 HELIX 4 4 ASN A 689 ASN A 708 1 20 HELIX 5 5 THR A 712 GLU A 737 1 26 HELIX 6 6 GLN B 629 LYS B 647 1 19 HELIX 7 7 ASP B 664 ILE B 669 1 6 HELIX 8 8 ASP B 674 ALA B 684 1 11 HELIX 9 9 ASN B 689 ASN B 708 1 20 HELIX 10 10 THR B 712 ALA B 736 1 25 SITE 1 AC1 5 ASN A 698 SER A 702 HOH A2079 ARG B 722 SITE 2 AC1 5 GLU B 723 SITE 1 AC2 12 ILE A 635 ASN A 651 ILE A 652 GLU A 655 SITE 2 AC2 12 VAL A 657 PRO A 658 GLU A 661 ASN A 708 SITE 3 AC2 12 PHE A 714 GLN A 735 HOH A2048 HOH A2131 SITE 1 AC3 11 LYS B 639 ASN B 651 ILE B 652 GLU B 655 SITE 2 AC3 11 VAL B 657 PRO B 658 GLU B 661 ASN B 708 SITE 3 AC3 11 PHE B 714 HOH B2046 HOH B2107 CRYST1 89.060 68.120 58.750 90.00 126.10 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011228 0.000000 0.008188 0.00000 SCALE2 0.000000 0.014680 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021066 0.00000